The phenanthridine biguanides efficiently differentiate between dGdC, dAdT and rArU sequences by two independent, sensitive spectroscopic methods by Radić Stojković, Marijana et al.
CREATED USING THE RSC ARTICLE TEMPLATE (VER. 3.1) - SEE WWW.RSC.ORG/ELECTRONICFILES FOR DETAILS 
ARTICLE TYPE www.rsc.org/xxxxxx  |  XXXXXXXX 
This journal is © The Royal Society of Chemistry [year] Journal Name, [year], [vol], 00–00  |  1 
The phenanthridine biguanides efficiently differentiate between dGdC, 
dAdT and rArU sequences by two independent, sensitive spectroscopic 
methods. 
Marijana Radić Stojković,a Snežana Miljanić,b Katarina Mišković,c Ljubica Glavaš-Obrovac,c,d Ivo 
Piantanida a* 
Received (in XXX, XXX) Xth XXXXXXXXX 200X, Accepted Xth XXXXXXXXX 200X 
First published on the web Xth XXXXXXXXX 200X 
DOI: 10.1039/b000000x 
At submicromolar concentrations two novel phenanthridine biguanides exhibit distinctly different 
spectroscopic signals for dGdC and dAdT sequences, respectively, by opposite fluorimetric 
changes (quenching for dGdC and increase for dAdT) and especially bis-biguanide derivative gives 
opposite ICD response (negative ICD for dGC and strong positive for dAdT). This speci fic 
signalling was explained by ability of compounds to switch binding mode from intercalation into 
dGdC to minor groove binding into dAdT sequences. Both compounds bind to rArU by 
intercalation, yielding different fluorimetric and CD response in comparison to any of 
aforementioned ds-DNA. Moreover, both compounds revealed significantly higher affinity toward 
ds-polynucleotides in comparison to previously studied alkylamine- and urea-analogues. 
Furthermore, DNA/RNA binding properties of novel compounds could be controlled by pH, due to 
the protonation of heterocyclic nitrogen. Low in vitro cytotoxicity of both compounds against 
human cell lines makes them interesting spectrophotometric probes.  
Introduction 
The recognition of specific nucleic acid sequences by novel 
small molecules has been the subject of a large number of 
studies over many years.1 Moreover, small molecules emitting 
specific or at least highly selective signals upon binding to 
certain DNA/RNA sequences are important for many 
technologies used in the molecular biology and medicine.2 
Small organic molecules can bind to DNA by means of a non-
specific (mainly electrostatic) binding along the DNA 
exterior, a specific groove binding and intercalation which is 
characterized by insertion of planar aromatic molecules 
between base pairs and is generally independent of base pair 
sequence.3  
Phenanthridine moiety or its close analogues (e.g. 4,9-
diazapyrene) were often applied for an “aryl” component due 
to characteristic structural features like a permanent or pH 
induced positive charge, high polarizability, high electron 
affinity and highly polar amino groups.4 In addition, it was 
shown that the chemical modulation of the phenanthridine 
exocyclic amines is a profitable option to tune the nucleic acid 
recognition properties of phenanthridinium dyes.5 A lot of 
experimental data on ethidium derivatives have been collected 
over the last three decades6 including a design of two-colour 
RNA intercalating probe for cell imaging applications7, 
photoaffinity labelling8 and antibiotic as well as antitumor 
activity.9-12 Also, recent study demonstrated that double 
amine-guanidine substitution at the 3 and 8 positions of the 
ethidium bromide changed the original intercalator into a 
minor groove binder of DNA.13 Moreover, a single amine-
guanidine exchange in known intercalators (anthracene, 
pyrene, tiophene, fluorene) resulted in a marked gain of 
affinity and antiproliferative activity while keeping their 
intercalative mode of binding.14 Furthermore, by taking 
advantage of weakly acidic pK of phenanthridine heterocyclic 
nitrogen, it was possible to efficiently and reversibly control 
some interactions with DNA/RNA by external stimuli (pH), as 
it was previously shown for aliphatic amine – phenanthridine 
conjugates.15 In our very recent studies, we noticed that 
electron-rich substituent as urea attached at 8- position of 
phenanthridine can induce intriguing fluorimetric specificity 
against AT (emission increase) and GC (emission quenching) 
basepairs, which was not previously reported for 
phenanthridine derivatives.16 All aforementioned inspired us 
to design novel phenanthridine derivatives equipped at 3 
and/or 8 positions with substituents which can actively 
participate in non-covalent binding to DNA/RNA, due to 
steric and electronic properties differentiate between various 
secondary structures and/or basepair composition of 
polynucleotide and report that recognition in the 
spectroscopically feasible form. 
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Scheme 1. Novel biguanide-phenanthridine conjugates 5 and 6, and 
their previously studied aliphatic amine-phenanthridine conjugates 7 and 
817,18 and urea analogue 9.16 
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In a search for promising substituents based on our knowledge 
on urea,16 amidine5 and guanidine derivatives,5 we came 
across biguanides, whose extended structure in preliminary 
modelling studies pointed toward intriguing combination of 
binding and steric interactions. Structural features of such 
biguanide-phenanthridine conjugates imply interactions 
between biguanide and DNA/RNA phosphate as well as 
possible hydrogen bonding of biguanide(s) with nucleobases 
within one of the DNA/RNA grooves analogously to recently 
shown guanidiniocarbonyl pyrrole interactions.19 Moreover, 
since the early 1900's, biguanides and substituted biguanides 
containing the active guanidine moiety have proven useful for 
the treatment of hyperglycemia, malaria and influenza20. Also, 
biguanide derivatives played important roles in elucidating 
many interesting aspects of coordination chemistry.21 
Moreover, biguanides are well known for their 
antimicrobial,22 antimalarial,23 antidiabetic24 and antitumor 
properties.25  
Therefore, we decided to study an influence of biguanide 
substituents attached to the 3 and/or 8 position of the 
phenanthridine ring (compounds 5, 6; Scheme 1) on the 
binding mechanism of these ligands to DNA/RNA and on 
their cytotoxic activity. Moreover, to investigate the impact of 
biguanide- substituents, obtained results are compared with 
previously studied analogues (Scheme 1) equipped either with 
inert aliphatic substituents (7, 8) or binding-active urea 
substituent (9). Furthermore, the antiproliferative activity of 
biguanide-phenanthridine conjugates against tumour cell lines 
and normal cells was also assayed. 
Results and discussion 
Synthesis 
The most of the arylbiguanides are prepared by the aqueous 
method of Curd and Rose26 although in several cases pyridine 
was employed as a solvent. Phenyl 6-methylphenanthridin-8-
yl carbamate and diphenyl 6-methylphenanthridine-3,8-diyl 
dicarbamate were used as the starting material for the 
synthesis procedure (Scheme 2). Protected phenanthridines 
were prepared in four steps, starting from the commercially 
available 2-aminobiphenyl, by the Morgan-Walls reaction27 
based on the middle pyridine ring formation by intramolecular 
electrophilic cyclization of the 2-amidobiphenyl derivative 
using POCl3. Removal of phenyloxycarbonyl protection from 
compounds 1 and 2 was achieved by heating at 120C under 
acidic condition. The reaction of aminophenathridine with 3M 
hydrochloric acid and dicyandiamide26 afforded compounds 5 
and 6 in 59 and 39% yields, respectively. 
Spectroscopy 
Compounds 5 and 6 due to the biguanide substituents were 
much better soluble in aqueous solutions (5, c=1.7  10-3 mol 
dm-3, 6, c=1.4  10-3 mol dm-3) than previously studied 8 and 
9. Buffered aqueous solutions of studied compounds were 
stable for several months. The absorbencies of 5 and 6 (Figure 
1) were proportional to their concentrations up to c=2-2.510-
5 mol dm-3, changes of the UV/Vis spectra on the temperature 
increase up to 95oC were negligible and reproducibility of 
UV/Vis spectra upon cooling back to 25oC was excellent. All 
mentioned is indicating that studied compounds do not 
aggregate by intermolecular stacking at experimental 
conditions used. Absorption maxima and corresponding molar 
extinction coefficients () are given in Table 1. 
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Scheme 2. Synthesis of phenanthridine biguanides 5 and 6. Reagents and 
conditions: a) (1) 70% H2SO4, 110-120C, (2) NaOH-H2O b) 3M HCl, 
H2NC(=NH)NHCN, 90-100C. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1 Left) UV/Vis spectra of 5 and 6 at c = 2 × 10-5 mol dm-3; Right) 
Fluorescence emission spectra of 5 and 6 at c= 2.8 × 10-6 mol dm-3; pH 
7.0, buffer sodium cacodylate, I = 0.05 mol dm-3, pH 5.0, citric 
acid/NaOH buffer, I = 0.03 mol dm-3. 
Table 1 Electronic absorption maxima and corresponding molar 
extinction coefficients in aqueous medium,a,b fluorescence emission 
maxima and corresponding relative quantum yieldsc. 
UV/Vis Fluorescence emission,      Q c 
max  (nm) /   10
3 (dm3mol-1cm-1) 
max  (nm) pH 5.0 pH 7.0 
pH 5.0 pH 7.0 
5 272 / 34.86 270 / 32.61 460a/399b 0.026 0.060 
6 280 / 31.68 277 / 30.79 485a/427b 0.017 0.023 
 
a Buffer pH 5.0 (citric acid/NaOH buffer, I = 0.03 mol dm-3). b Buffer pH 
7.0 (buffer sodium cacodylate, I = 0.05 mol dm-3).c Relative quantum 
yield (Q) was determined with respect to L-N-acetyltryptophanamide 
(NATA) standard59 (Q = 0.14). 
The emission intensities (Figure 1) of buffered aqueous 
solutions (buffer sodium cacodylate, I = 0.05 mol dm-3, pH 
7.0, citric acid/NaOH buffer, I = 0.03 mol dm-3, pH 5.0) of 
studied compounds are proportional to their concentrations up 
to c = 3-4  10-6 mol dm-3, changes of the emission spectra on 
the temperature increase up to 45oC were only minor at pH 7.0 
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but somewhat stronger at pH 5.0 and reproducibility of 
emission spectra upon cooling back to 25oC was excellent. 
The excitation spectra agree well with corresponding 
absorption spectra in the region where emission and excitation 
spectrum do not overlap. 
Continuous variation of pH resulted in changes of 
fluorescence emission intensity of 5 (Figure 2) and 6 
characterised by two transition steps, which allowed an 
estimation of the pK1a value  5.2 and pK2a value  11.3. In 
order to obtain more precise pKa values, potentiometric 
titration of 5 (data not shown) was performed within pH 3 – 
11 range, giving pKa1= 5.5 and pKa2= 10.2. The first 
transition step can be attributed to the protonation equilibrium 
of phenanthridine nitrogen (pKa  6),17,18 with well separated 
protonated (max = 462 nm) and non-protonated nitrogen 
species (max = 399 nm), whereas latter transition step can be 
attributed to the protonation equilibrium of biguanide 
moiety.28 Consequently, at acidic pH (pH 5.0, citric 
acid/NaOH buffer, I=0.03 mol dm-3) phenanthridine nitrogen 
of 5 and 6 is mostly protonated (76%), consequently 5 is 
characterized by two positive charges and 6 (with two 
biguanide groups) has three positive charges. On the other 
hand, at neutral conditions (pH 7.0, buffer sodium cacodylate, 
I = 0.05 mol dm-3) phenanthridines of 5 and 6 are not 
protonated and compounds are characterized by one or two 
positively charged biguanides, respectively.   
 
Fig.¸2 The pH dependent changes of fluorescence emission spectrum of 5 
(c= 2.0  10-6 mol dm-3); exc = 272 nm (left); Dependence of 5 
fluorescence intensity at max  = 462 nm on the pH of the aqueous solution 
(right). 
Study of interactions of 5 and 6 with ds- DNA and ds-RNA in 
aqueous medium 
Spectrophotometric titrations 
 In all titration experiments, equilibrium was achieved 
within 2 min upon mixing DNA or RNA with studied 
compound. Such kinetics of binding is common for small 
molecules, both for intercalators (e.g. ethidium bromide) and 
minor groove binders (e.g. DAPI or related derivatives), thus 
ruling out some secondary processes like degradation of 
compounds upon DNA/RNA binding or formation of more 
complicated complexes like threading intercalation or self-
stacking agglomerates of porphyrins. 
UV/Vis titrations were not applicable for study of interactions 
of 5 and 6 with ds-DNA and RNA due to their low molar 
extinction coefficients at   300 nm. Nevertheless, strong 
fluorescence emission of the 5 and 6 aqueous solutions 
allowed titration studies. At both pH, all studied compounds 
showed similar fluorimetric changes toward ds-DNA and ds-
RNA. However, fluorescence changes were strongly 
dependent on a structure of the polynucleotide, whereby 
addition of dAdT polynucleotide (at excess of a 
polynucleotide, Figure 3, Up) resulted in emission increase of 
5 and 6, while titration with dGdC polynucleotide (Figure 3, 
Down) yielded strong fluorescence quenching for both 
compounds. 
 Such a specific fluorimetric differentiation between AT and 
GC sequences was not common for phenanthridine moiety, 
whose fluorescence is either non-selectively enhanced 
(ethidium bromide analogues) or completely quenched 
(derivatives with no amino-substituents at 3,8 positions).4,5 
Actually very few compounds reveal such emission specificity 
(some 4,9-diazapyrenium cations29 and acridine derivatives30) 
and only very recently urea-phenanthridine conjugate (e.g. 
compound 9, Scheme 1).16 That dAdT vs dGdC fluorescence 
specificity was correlated to intercalation of mentioned 
compounds into ds-DNA, whereby only aromatic stacking 
interactions with guanine base yielded quenching (due to the 
electronic property of guanine, being the most electron-
donating of all four nucleobases).30,31 
 
Fig. 3 Up) Changes of fluorescence spectrum of 6 (c= 1.0 × 10-6 mol dm-
3) upon titration with poly dA – poly dT; Down) Changes in fluorescence 
spectrum of 6 (c= 1.3  10-6 mol dm-3) upon titration with poly dG – poly 
dC; Done at pH 7.0, buffer sodium cacodylate, I = 0.05 mol dm-3. 
However, fluorimetric changes of 5 and 6 upon addition of ds-
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RNA (poly rA-poly rU) revealed different pattern in 
comparison to DNA polynucleotides. Namely, at pH 7.0 poly 
rA-poly rU induced fluorescence quenching of 5 at maximum 
(em = 400 nm, which is assigned to non-protonated 
phenanthridine nitrogen form according to Figure 2), while at 
the other maximum (463 nm) it increased fluorescence of 5 
(Figure 4). Such a change along with systematic deviation 
from isosbestic point (420-430 nm) indicates formation of two 
different 5-poly rA – poly rU complexes. At 463 nm 
maximum, a few first aliquots of poly rA – poly rU yielded a 
minor quenching of 5 fluorescence until ratio r [5] / [poly rA – poly 
rU ] = 0.042 and further addition of poly rA – poly rU yielded 
significant fluorescence increase. Similar dual fluorimetric 
responses but with emphasis on the increase of 6 fluorescence 
at one maximum wavelength (em = 485 nm, which is ascribed 
to protonated phenanthridine nitrogen form analogously to 5 
in Figure 2) were observable in titrations with poly rA – poly 
rU at pH 5.0 and pH 7.0. Such mixed binding modes of 5 and 
6 to poly rA – poly rU could not be resolved according to the 
fluorimetric titrations only, but other independent methods 
were necessary. 
 
Fig. 4 Changes in fluorescence spectrum of 5 (c= 1.0  10-6 mol dm-3) 
upon titration with poly rA – poly rU; at pH 7.0, buffer sodium 
cacodylate, I = 0.05 mol dm-3. 
Processing of the fluorescence titration data collected at 
excess of polynucleotide over compound by means of 
Scatchard equation32 gave binding constants Ks and ratios 
n[bound compound]/ [polynucleotide] (Table 2). In case of 5 with poly rA 
– poly rU, titration data of both fluorescence quenching and 
increases were separately processed by means of Scatchard 
equation. At neutral conditions, 5 revealed somewhat stronger 
affinity toward poly rA – poly rU and poly dA – poly dT 
compared to poly dG - poly dC.  
The most importantly, previously studied aliphatic analogues 
7 and 8 as well as urea-analogue 9 (Scheme 1) revealed 10-
100 times lower affinity toward corresponding DNA and RNA 
than here presented 5 and 6, which clearly points to 
significant contribution of biguanide substituents in 
DNA/RNA binding. 
Table 2 Binding constants (logKs)a and ratios nb ([bound compound]/ 
[polynucleotide phosphate]) calculated from the fluorescence titrations of 
5 and 6 with ds- polynucleotides at pH 5.0 (citric acid/NaOH buffer, I = 
0.03 mol dm-3 ) and pH 7.0 (buffer sodium cacodylate, I = 0.05 mol dm-3) 
  
5 6 
  I/I0
c log 
Ks 
n I/I0
c log 
Ks 
n 
 
pH 
5 
poly rA -
poly rU  
3.05 6.96 0.098 5.47 7.36 0.15 
poly dA-
poly dT 
2.36 6.98 0.04 4.24 7.4 0.089 
poly dG - 
poly dC 
0 6.81 0.05 0 6.63 0.105 
 
pH 
7 
poly rA -
poly rU  
0.76d 
1.9 e 
5.96 
7.53 
 0.1 
0.01 
10.1 5.73 
 
0.33 
 
poly dA-
poly dT 
1.76 7.59 0.007 5.84 6.52 0.071 
poly dG - 
poly dC 
0.4 5.56 0.6 0 5.80 0.29 
 
a Titration data were processed according to the Scatchard equation;32 b 
Accuracy of n  10 - 30%, consequently logKs values vary in the same 
order of magnitude c I0 – starting fluorescence intensity of 5 and 6; I – 
fluorescence intensity of 5, 6 /polynucleotide complex calculated by 
Scatchard equation. d  Data calculated by the Scatchard equation from the 
part of titration experiment (max = 400 nm) with poly rA – poly rU in 
which starting fluorescence of 5 was quenched. e Data calculated by the 
Scatchard equation from the part of titration experiment (max = 463 nm) 
with poly rA – poly rU in which fluorescence of primarily formed 
complex 5–poly A–polyU was enhanced by formation of secondary 
complex. 
Circular dichroism experiments  
So far, non-covalent interactions at 25C were studied by 
monitoring the spectroscopic properties of studied compound 
upon addition of the polynucleotides. The CD spectra of the 
ligand-polynucleotide complexes can provide information on 
two levels.33 First, the conformation change of polynucleotide 
upon small molecule binding can be probed through the 
changes of the intrinsic polynucleotide CD spectrum. Second, 
achiral small molecules could acquire an induced CD (ICD) 
signal when they form complexes with a polynucleotide from 
which a mutual orientation of small molecule and 
polynucleotide chiral axis could be derived, consequently 
giving an useful information about modes of interaction.34,35 It 
should be noted that here studied compounds 5 and 6 are 
achiral and therefore do not possess intrinsic CD spectrum. 
Since studied compounds display the UV/Vis spectra in the 
245 – 350 nm region (Figure 1), the ICD bands observed at λ 
 300 nm can be attributed to them. 
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a)       b) 
Fig. 5 CD titrations of a) poly dA – poly dT and b) poly dG-poly dC (c = 3.0  10-5 mol dm-3) with 6 at molar ratios r = [compound] / [polynucleotide] 
(pH 5.0, citric acid/NaOH buffer, I = 0.03 mol dm-3). 
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a)       b) 
Fig. 6 CD titrations of a) poly dA – poly dT and b) poly dG-poly dC (c = 3.0  10-5 mol dm-3) with 5 at molar ratios r = [compound] / [polynucleotide] 
(pH 5.0, citric acid/NaOH buffer, I = 0.03 mol dm-3). 
 
a)      b) 
Fig. 7 CD titration of poly rA-poly rU (c = 3.0  10-5 mol dm-3) with 5 (a) and 6 (b) at molar ratios r = [compound] / [poly rA-poly rU ] (pH = 5.0, citric 
acid/NaOH buffer, I = 0.03 mol dm-3). 
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In general, changes in CD spectra of studied polynucleotides 
obtained upon mixing with 5 and 6 were dependent on a pH of 
the solution, whereby protonation of the heterocyclic nitrogen 
of 5, 6 resulted in stronger changes in the CD spectra of ds-
DNA and RNA at pH 5.0 (Figures 5 and 6).  
In the most CD experiments the ICD signals for both 5 and 6 
differed at ratio r[dye]/[polynucleotide]<0.2 and r >> 0.2. For both, 
intercalative and minor groove binding mode, at at ratios 
below r<0.2 there is an excess of binding sites over 
concentration of 5 or 6, thus allowing each of small molecules 
to bind to its own binding site – consequently observed ICD 
bands can be attributed to one dominant binding mode. 
However, when all dominant binding sites filled (at ratios r >> 
0.2, excess of 5 or 6 over the binding sites), excess of small 
molecules still tends to bind to polynucleotide, by forming 
aggregates along double helix. For instance, at such 
conditions even ethidium bromide and many other 
intercalators bind by non-intercalative binding mode, and 
many minor groove binders tend to form dimers within the 
grooves (e.g. cyanine dyes).35  
At both pH 5.0 and pH 7.0, additions of 5 and 6 into AT-
polynucleotide solutions resulted in very strong positive ICD 
bands within the 290-350 nm range, which is indicative of 
minor groove binding to the AT sites.36 A clear isoelliptic 
point at 252 nm for ratio r=0 – 0.3 (Figure 5 and Figure 6) 
pointed toward formation of one dominant type of 
5,6/polynucleotide complex.  
A completely different pattern was observed in CD 
experiments of dGdC polynucleotides with 5 and 6. The weak 
negative ICD band at   290 nm obtained at low ratios r[5,6] / 
[dGdC] = 0 - 0.2 for both, 5 and 6 (Figures 5 and 6), which 
reflects an orientation of the phenanthridine chromophore 
more or less coplanar to the plane of polynucleotide basepairs 
could be attributed to intercalation between basepairs.37 
However, at conditions of an excess of 5, 6 over intercalative 
binding sites ( r[5,6]/ [dGdC]  0.2) stronger negative ICD bands 
appear accompanied by systematic deviation from the 
isoelliptic points, which suggests agglomeration of 5, 6 along 
DNA.  
Addition of 6 induced changes in CD spectra of ctDNA 
(composition 58% AT, 42% GC) similar to those with AT-
polynucleotides (the increase of CD spectra in the 260-290 
region and strong positive ICD at   290 nm) at both, pH 5.0 
and pH 7.0. Contrary to 6, no positive ICD band at   290 
nm was observed for ctDNA-5 complex at both pH which 
could be the consequence of mixed binding modes, e.g. minor 
groove binding in AT rich sequences and intercalation into 
GC-rich sequences.  
Similarly to fluorimetric titrations, CD experiments with poly 
rA- poly rU (Figure 7) differed significantly from analogous 
AT-DNAs (Figures 5a, 6a), whereby intensity of CD spectrum 
of poly rA - poly rU strongly decreased and intensity of CD 
spectrum of poly dA – poly dT increased. Moreover, strong 
positive ICD bands at   290 nm obtained for AT-DNAs 
contrasted very weak positive or even negative ICD bands at  
 290nm observed for poly rA - poly rU . Another prominent 
difference was evidenced at pH 7 (ESI†), at which CD spectra 
of poly rA - poly rU changed only negligibly, at variance to 
moderate to strong changes in CD spectra of AT-DNAs.  
Absence of strong positive ICD band at   290 nm excludes 
binding of 5, 6 into minor groove of ds-RNA, which is 
anyway too broad and shallow39 to efficiently bind such small 
molecules.3 However, a weak positive ICD band (  290 nm) 
observed at ratios r[5,6]/ [poly rA – poly rU ]  0.3 can be attributed 
to intercalation of 5, 6 into poly rA - poly rU , whereby 
positive sign implies orthogonal orientation of the longer axis 
of phenanthridine in respect to the longer axis of adjacent 
basepairs.35 Intriguingly, almost the same changes in CD 
spectrum of poly A- poly rU were observed for urea-analogue 
916 (ESI†), a proven RNA intercalator. The most prominent 
changes in CD spectra in the range 260 – 300 nm observed at 
the excess of 5, 6 over the intercalation binding sites (r>>0.3), 
can be attributed to the non-specific agglomeration of non-
intercalated molecules along double helix.34,35  
Thermal denaturation experiments 
The melting temperature (Tm) is defined as the temperature at 
which half of the DNA strands are in the double-helical state 
and half are in the "random-coil" states. It depends on both the 
length of the molecule and the specific nucleotide sequence 
composition of that molecule. It can also be influenced by salt 
concentration and pH. Non-covalent binding of small 
molecules to ds-polynucleotides usually has certain effect on 
the thermal stability of helices thus giving different Tm values. 
Difference between Tm value of free polynucleotide and 
complex with small molecule (Tm value) is important factor 
in characterisation of small molecule / ds-polynucleotide 
interactions.38 
 
Fig. 8 Thermal denaturation of studied polynucleotides upon 
addition of 6. Ratio r[6] / [polynucleotide] =0.3, pH 5.0 (citric acid/NaOH 
buffer, I = 0.03 mol dm-3).  
 At both, pH 5 and 7, for all studied polynucleotides, 
thermal stabilization effects (Table 3, Figure 8). were 
proportional to the number of positive charges attached to the 
phenanthridine moiety, consequently the highest Tm values 
were obtained for 6 (2+ at pH 7, 3+ at pH 5), somewhat lower 
for 5 (1+ at pH 7, 2+ at pH 5) and significantly lower for 
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previously studied aliphatic analogues 7 and 8 as well as urea-
analogue 9 (neutral at pH 7, 1+ at pH 5), which again clearly 
points to significant contribution of biguanide substituents in 
DNA/RNA binding.  
More detailed examination of results at pH 5 revealed that 
stabilization effects observed for AT and rArU 
polynucleotides were comparable (for each compound alone) 
and for mixed sequence (ct-DNA, 58% AT, 42% GC) 
somewhat lower. 
Intriguingly, at pH 7 only bis-biguanide derivative 6 
significantly stabilized all studied polynucleotides, whereby 
AT-sequences were significantly stronger stabilized than AU- 
or mixed (ct-DNA) sequence. Mono-biguanide derivative 5 
stabilized weakly only alternating AT-sequence.  
 
Table 3 The aTm values ( °C ) of studied ds- polynucleotides upon addition of different ratios 
br of 5 and 6 at pH 5.0 (citric acid/NaOH buffer, I = 0.03 
mol dm-3 ) and pH 7.0 (buffer sodium cacodylate, I = 0.05 mol dm-3 ). 
  5 6 817 916 
 br[compound] / [polynucleotide] = 0.1 0.2 0.3 0.1 0.2 0.3 0.3 0.3 
 
pH 5 
ctDNA 6.6 8.7 10.4 14.5 20.6 22.3 - 2.4 
poly dA-poly dT 6.7 9.3 11.4 26.3 29.5 32.2 13.0 0.7 
poly rA - poly rU  
12.2/ 
0c 
15/ 
-0.5c 
16.7/ 
-0.5c 
35.1/ 
-0.7c 
35.4/ 
-1.8c 
36.5/  
-2.1c 
7.9/ 
0c 
3.4/ 
0c 
poly dAdT - poly dAdT 10.6 13.7 16.2 21.8 25 30 2.0 - 
 
pH 7 
ctDNA 0 0 0 3.7 5.6 7.3 - - 
poly dA-poly dT 0.3 0.4 0.5 7.2 9.8 11.7 - - 
poly rA - poly rU  0 0 0 3.5 5.0 6.5 
- 
- 
poly dAdT - poly dAdT 1.2 1.9 2.5 7.0 10.3 12.1 
- 
- 
 
a Error in Tm :  0.5°C; b r = [compound] / [polynucleotide]; c Biphasic transitions: the first transition at Tm = 30.5 oC is attributed to denaturation of poly 
rA –poly rU and the second transition at Tm = 85.9 
oC is attributed to denaturation of poly AH+-poly AH+ since poly rA at pH 5.0 is mostly protonated and 
forms ds-polynucleotide39. 
Viscometry measurements 
The increase in ds-DNA/RNA contour length, which should 
happen upon intercalation of aromatic moiety, is conveniently 
monitored by measuring the viscosity of sonicated rodlike 
fragments of ds-DNA/RNA as a function of ligand binding 
ratio, r[compound] / [polynucleotide]. Cohen an Eisenberg have 
deduced that the relative increase in contour length in the 
presence of bound drug is approximated by the cube root of 
the ratio of the intrinsic viscosity of the DNA-drug complex to 
that of the free DNA (equation in Materials and Methods).40 
Classical monointercalators like ethidium bromide, proflavine 
and 9-aminoacridine have values of helix extension parameter 
(viscosity index),  of about 0.8-0.9 while extension 
parameters of bisintercalators are usually in the range 1.5-
1.9.40 Complexes and ligands that bind exclusively or at least 
partially in the DNA grooves typically cause less pronounced 
or no changes in DNA/RNA solution viscosity. 
Viscometry experiments (ESI†) were performed with ct-DNA 
and poly rA – poly rU at pH 7.0 (buffer sodium cacodylate, I 
= 0.05 mol dm-3). The values of helix extension parameter for 
poly rA – poly rU were  = 0.77 ± 0.05 (5), 0.91 ± 0.06 (6), 
latter value agreeing well with the value obtained for ethidium 
bromide ((EB) = 1.02 ± 0.08). Those results strongly support 
intercalation of 6 into poly rA – poly rU as the dominant 
binding mode, while  value obtained for 5 suggested mixed 
binding mode or agglomeration along RNA double helix. For 
ct-DNA values of  = 0.62 ± 0.06 (5), 0.31 ± 0.03 (6) are only 
half of the value found for EB ( =1.04 ± 0.09). Since ct-
DNA consists of mixed sequence (42% GC basepairs/58%AT 
basepairs), obtained  values suggest intercalation of 5, 6 in 
the GC-rich sequences resulting in significant DNA 
elongation (e.g.   1) and minor groove binding in AT rich 
domains, which should have only minor impact on DNA 
elongation due to the stiffening of double helical structure – 
thus overall ctDNA elongation should be about  =0.4-0.5. 
That presumption is additionally supported by experiments 
performed with dGdC and dAdT polynucleotides (ESI†), 
whereby ratio 5/EB= 0.8 ± 0.14 clearly points that 5 
elongates dGdC sequence similarly to ethidium bromide, 
while ratio 5/EB= 0.48 ± 0.11 is much lower and therefore 
excuded intercalation as a dominant binding mode.52 
Surface-enhanced Raman spectroscopy 
Surface-enhanced Raman spectroscopy (SERS) has been used 
as a powerful technique to study small molecules and their 
interactions with certain targets such as nucleic acids and 
intracellular enzymes.41-46 When adsorbed on the metal 
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surface fluorescence of the drug molecules is quenched, at the 
same time Raman scattering being enhanced by several orders 
of magnitude. A large amount of a biological sample usually 
required for conventional Raman measurements (10–2 M) is 
avoided preserving information on structural features of 
species at concentrations as low as 10–8 M. During adsorption 
of the drug/DNA complex on the surface of the silver 
nanoparticles neither perturbations of the molecular 
interactions nor changes in the structure of complexes have 
been obtained.42,43 
Surface-enhanced Raman spectra of the phenanthridine 
biguanides 5 and 6 and their complexes with ct-DNA were 
measured in the silver citrate colloid (Figures 9 and 10). A 
tentative assignment of the observed vibrational bands is 
given in ESI† (Table S1). The bands are mainly assigned to 
the stretching and deformation modes of the phenanthridine 
moiety and CN bonds as well as to bending of amino groups 
in the biguanide substituents.47-50 In agreement with the 
vibrational analysis of inorganic and organic salts of 
biguanide, one band often arises from a mixed vibration 
involving different functional groups.49,50 
Since the buffered solution of the nucleic acid (pH 7.0) was 
used for preparation of the 5,6/DNA mixtures, influence of the 
cacodylate buffer on the 5,6 SERS spectra was examined first. 
The SERS spectrum of 5 in the presence of the buffer solution 
is almost identical to its SERS spectrum without the buffer. 
For 6, however, intensity of the band at 1426 cm1 associated 
with CN stretching and NH2 bending decreased. Slight 
enhancement of the bands in the region below 1000 cm1 in 
the spectra of both compounds implies mild aggregation of the 
silver nanoparticles, most likely induced by the chloride ions 
present in the buffer solution.     
Upon addition of ct-DNA in the silver colloids containing 
biguanide species ([5,6]/[DNA] 1/20) the Raman scattering 
was less enhanced than that observed in the colloids 
containing 5 and 6 alone (Figures 9 and 10). Due to a short 
range character of the Raman enhancement it can be assumed 
that interacting with the nucleic acid, biguanide molecules 
either change their orientation relative to the metal 
nanoparticles to the position where polarizability change 
contributes to a lesser degree to the scattering or move away 
from the enhancing surface. Moreover, a band at 227 cm1 
assigned to the AgN stretching in the phenanthridine 
biguanides spectra, shifts towards 224 and 223 cm1 in the 
SERS spectra of 5/DNA and 6/DNA, respectively. The 
observed downshift indicates weakening of the bond between 
the phenanthridine biguanides and the silver surface in the 
presence of DNA.  
A shoulder at 1616 cm1 in the spectrum of 5, which is 
attributed to the stretching of the double CN bond, turns into a 
band at 1612 cm1 in the spectrum of 5/DNA (Figure 9). A 
shift towards lower wave numbers is also observed for bands 
at 1422, 1229 and 1007 cm1 which are assigned to coupling 
of the CN stretching and NH bending modes. It can be 
assumed that due to interactions with DNA, electrons are 
drawn from the C=N bond that lowers the bond order and 
hence the frequency of the C=N stretching.51 In the same way 
CN bonds weaken, resulting in lower vibration energies. 
However, some vibrational bands of 5, such as those at 1210, 
1076 and 588 cm1, are upshifted in the presence of DNA and 
appear at 1212, 1081 and 600 cm1 in the spectrum of the 
complex. These weak bands are associated predominantly 
with the NH bending mode. It is very likely that deformation 
motions of the amino groups are “stiffened” by hydrogen 
bonding with the nucleic acid, requiring higher energy for 
vibration.51 Wavenumbers of the intense bands assigned to the 
stretchings of the phenanthridine moiety do not significantly 
change in the spectrum of the complex, however, their 
intensities relative one to another do. Thus the ratio of the 
Raman intensity of the bands at 1345 and 1391 cm1, which is 
1.30 for 5 alone, decreases to the value of 1.15 in the 
spectrum of 5/DNA. The obtained change in the relative band 
intensity indicates that due to interaction with DNA the 
phenanthridine plane adopt tilted position relative to the silver 
surface giving rise to differently enhanced ring modes.  
 
Fig. 9 SERS spectra of a) 5 and b) [5]/[ctDNA] 1/20. c(5) = 510–5 M, pH 
7.0, buffer sodium cacodylate, I = 0.05 mol dm-3. 
 
Fig. 10 SERS spectra of a) 6 and b) [6]/[ctDNA] 1/20. c(6) = 510–5 M, 
pH 7.0, buffer sodium cacodylate, I = 0.05 mol dm-3. 
 
Changes in the SERS spectrum of the compound 6 having two 
biguanide moieties in interaction with DNA resemble those 
observed in the spectrum of 5/DNA (Figure 9). Intensity of a 
band at 1426 cm1 assigned mainly to the CN stretching 
decreases, forming a shoulder at 1419 cm1 in the spectrum of 
1800 1600 1400 1200 1000 800 600 400 200
b
 
 
R
a
m
a
n
 I
n
te
n
s
it
y
Wavenumber / cm
-1
a
 
1800 1600 1400 1200 1000 800 600 400 200
 
 
R
a
m
a
n
 I
n
te
n
s
it
y
Wavenumber / cm
-1
a
b
 
 This journal is © The Royal Society of Chemistry [year] Journal Name, [year], [vol], 00–00  |  9 
the 6/DNA complex. On the other hand, a medium band at 
1277 cm1, which beside the in plane CH deformations 
corresponds to the NH bending, shifts towards a higher 
wavenumber, 1284 cm1. Unlike the spectrum of 5/DNA, 
stretching of the double CN bond contributes along with the 
phenanthridine stretching vibrations to a very intense band at 
1621 cm1. Except from intensity decrease, a prominent 
change neither in shape nor in position was obtained for this 
strong band in the presence of DNA. 
 In the spectra of both, 5/DNA and 6/DNA, bands that 
originate from ring deformation at 727 and 722 cm1, 
respectively, appear at 729 cm1. Upward shift implies 
hindered bending of the phenanthridine part upon interaction 
with the nucleic acid. As for 5, the relative intensity of the 
ring modes changes, most likely as a consequence of the 
interaction induced change in position of the bound molecules 
of 6 close to the enhancing surface.  
In conclusion, quenching of the SERS intensity has been 
already interpreted as a loss of accessibility for DNA-bound 
ligands to the silver nanoparticles as a result of a drug binding 
into ds-DNA, by intercalation and/or minor groove binding.41-
44 Here, still remaining residual SERS signal indicates that 
both phenanthridine biguanides upon binding to the DNA 
helix still remain in contact with silver nanoparticles, 
although somewhat tilted in respect to the metal surface – that 
observation agrees much better with DNA minor groove 
binding than intercalation. In addition, more pronounced 
spectral changes for 5 than for 6 complex with ctDNA, if 
compared with the free biguanide molecules point to deeper 
and more tight insertion of bis-biguanide derivative (6), 
agreeing well with results of CD and especially thermal 
denaturation experiments. 
Discussion of the results of DNA/RNA binding studies 
The fluorimetric and CD titrations, thermal denaturation and 
viscometry experiments clearly indicate for 5 and 6 two 
different binding modes to ds-DNA’s: 1) minor groove 
binding within dAdT-sequences and 2) intercalation into 
dGdC-sequences.52 Moreover, shifting of some vibrational 
bands (predominantly associated with the NH bending mode) 
of 5 and 6 in the presence of ct-DNA also supported deeper 
and more tight insertion of bis-biguanide derivative (6) in 
comparison to mono-biguanide 5, agreeing well with results 
of CD and especially thermal denaturation experiments (only 
compound 6 stabilizes ct-DNA at pH 7).  
 The data obtained at pH 5 for 5 and 6 at ratios r[5, 6]/ [poly rA – 
poly rU ]  0.3 point to the intercalation into poly rA – poly rU.52 
However, at pH 7 mono-biguanide 5 did not stabilize ds-RNA 
against thermal denaturation and yielded intriguing specific 
dual fluorimetric response suggesting at least two different 
binding modes. Quenching of the fluorescence at 400 nm is 
probably the result of agglomeration of 5 molecules along the 
polynucleotide backbone, which is consistent with the 
observed minor changes of CD spectra of poly rA – poly rU at 
pH 7.0. At variance to 5, bis-biguanide 6 clearly stabilizes ds-
RNA even at pH 7, whereby CD titration and viscometry 
results support intercalation as a dominant binding mode.  
 Finally, affinity of 5 and 6 toward all studied DNA/RNA, 
as well as thermal stabilisation effects are one-two orders of 
magnitude higher than those found for previously studied 
aliphatic analogues 7 and 8 as well as urea-analogue 9, which 
clearly points to the significant contribution of biguanide 
substituents in DNA/RNA binding. 
Antiproliferative activity of 5 and 6 and discussion of 5,6 
bioactivity 
Since 5 and 6 revealed significant interactions with ds-DNA, 
we evaluated their in vitro cytotoxic activity by the MTT 
assay on a panel of eight human cell lines, six of which were 
derived from different cancer types including HeLa (cervical 
carcinoma), MCF-7 (breast carcinoma), AGS (gastric 
adenocarcinoma), MiaPaCa-2 (pancreatic carcinoma), HEp-2 
(laryngeal carcinoma), NCI-H358 (bronchioalveolar 
carcinoma), one from normal human fibroblasts, BJ, and one 
from canine Cocker Spaniel kidney, MDCK. Applied in 
concentration range 10-7 to 10-5 mol dm-3 compounds did not 
inhibited the growth of tumour and normal cells. According to 
the obtained results, antiproliferative activity of 5 was 
concentration and cell line dependent (ESI†). Compared to the 
inhibitory potential of compound 6, 0.1 mol dm-3 compound 5 
exhibited significant antiproliferative activity (Table 4). The 
significant influence of 5 on tumour cells growth compared to 
normal cells was not observed instead of different cell 
metabolism of tumour cells vs. normal cells53. As expected, 
the pancreatic adenocarcinoma cells, which are extremely 
resistant to conventional therapy54, were most resistant against 
applied compounds.  There are several factors that could 
explain a difference in growth inhibitory effects between two 
phenanthridine biguanides: smaller molecular weight of 
compound 5, one positive charge on the long axis of the 5 
molecules and amphiphilic nature of 5. All that factors can 
facilitate drug uptake across the tumour cell membrane which 
is greatly influenced by the interstitial and intracellular pH 
and the ionization properties of the drug55. Thus, the obtained 
data demonstrated how minor changes to the structure of these 
compounds can significantly influence on the final outcome in 
antitumor activity resulting in either significant antitumor 
activity in higher applied concentration (as for 5) or almost 
complete loss of antitumor activity (in case of 6).   
 
Table 4 IC50 – Compound concentration (µmol dm
-3) leading to cellular 
viability reduction by 50% compared to control cells after 72 h treatment. 
Data represent mean value of three independent experiments ± SD. 
Cytotoxic activity was analyzed by MTT assay. 
  IC50 (μmol dm
-3) 
 
AGS MiaPaCa2 CaCo-2 HEp-2 HeLa 
NCI-
H358 BJ MDCK 
5 
21.9± 
20.6 
> 100 
72.0 ± 
8.7 
57.6 ± 
11.8 
19.1 ± 
2.9 
> 100 
75.6 ± 
53.7 
90.3 ± 
11.0 
6 > 100 > 100 > 100 > 100 > 100 > 100 > 100 > 100 
 
Conclusions 
Here presented novel modification of phenanthridine 
exocyclic amines by introduction of biguanides at 3- (mono-
biguanide 5) or 3,8 (bis-biguanide 6) position significantly 
influenced DNA/RNA binding properties of phenanthridine 
moiety. Both compounds revealed significantly higher affinity 
toward ds-polynucleotides in comparison to previously 
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studied alkylamine- (7, 8) and urea-analogues (9), which 
clearly points to the significant contribution of biguanide 
substituents in DNA/RNA binding. Closer examination of 
previously studied bis-guanidinium derivatives of ethidium 
bromide pointed out that as small structural difference as 
permanently charged heterocyclic nitrogen can have a 
profound effect on DNA/RNA binding; whereby charged 
derivative is classical DNA intercalator5, while neutral 
derivative (DB950)13 showed DNA sequence-dependent 
binding modes. Structurally more similar to latter, neutral 
derivative of ethidium (DB950),13 5 and 6 also switch binding 
mode from intercalation into dGdC-DNA to minor groove 
binding to dAdT-DNA. Consequently, both compounds were 
able (especially bis-biguanide 6) to distinguish by YES-NO 
answer in two highly sensitive spectroscopic methods between 
dGdC (fluorescence quenching, negative ICD band) and dAdT 
(fluorescence increase, positive ICD band). All 
spectrophotometric changes take place at submicromolar 
concentrations due to the exceptionally high affinity of 5 and 
6 toward ds-DNA. Moreover, here presented results show that 
further increase of a molecule length (6 is longer than 
DB95013) and introduction of additional hydrogen-bonding 
possibilities within DNA minor groove (biguanide can form 
more H-bonds than guanidine) didn’t abolish intercalation of 
6 into dGdC.  
Moreover, 5 and 6 retained a capacity to intercalate into ds-
RNA, thus being promising structures to test against RNA 
target, the HIV-1 Rev Response Element (RRE), in line with 
profoundly modulated affinity and selectivity of ethidium-
urea, pyrrole, or guanidinium derivatives.5 
Such a switching of DNA/RNA binding mode is not a 
common property of small molecules,3,13 and usually it is 
associated with profound effects on biological activity and/or 
selective spectroscopic properties of complexes formed. 
Furthermore, specific vibrational bands of guanidine moiety 
allowed more detailed structural investigation of DNA 
complexes formed at biologically relevant conditions (10-50 
micromolar concentrations) by application of SERS 
spectroscopy, rather novel technique in DNA/RNA studies.  
The binding results of 5 and 6 to ds-DNA and ds-RNA 
indicated that pH of a solution and structure of both, 
polynucleotide and compound, have a great influence on the 
formation of a complex. At pH 5.0 due to the protonation of 
heterocyclic nitrogen, both compounds induced higher 
stabilization effects on polynucleotides and exhibited stronger 
changes in CD spectra than at pH 7.0. Advantages of a pH-
controlled DNA/RNA binding combined with selective 
spectrophotometric signalling could be employed in numerous 
biochemical studies, for instance solid tumours have 
significantly lowered extracellular pH56 and several 
antitumour drugs owe their preferential accumulation in 
tumour tissue due to weakly acidic pKa value55. Although low 
in vitro cytotoxicity of both compounds against human cell 
lines abolishes their application as antitumour drugs, just the 
same makes them interesting lead compounds for a 
development of novel low-toxic spectrophotometric probes.   
Future prospects in study of biguanide-phenanthridine 
derivatives associated to extended length and increased 
hydrogen-bonding possibility of 5 and 6 will be also related to 
interactions with triplex and quadruplex DNA and DNA/RNA 
constructs. Namely, recently was reported increased affinity 
of extended ethidium bromide derivative toward triple 
helices;57 as well as selective interactions of closely related 
ethidium edrivatives with various G-quadruplex DNA.58  
Experimental 
Synthetic procedures 
Synthesis of  1-(6-methylphenanthridin-8-yl)biguanide ∙ 2HCl 
(5). 
To a solution of 8-amino-6-methylphenanthridine (3; 0.19 g, 
0.91 mmol) and 3M hydrochloric acid (304 l, 0.033 g, 0.91 
mmol) was added dicyandiamide (0.0774 g, 0.91 mmol). The 
resulting suspension was stirred at 90-100C for 3-4 hours. 
The reaction mixture was then dissolved in methanol, filtered 
off and dried. After recrystallization from methanol, the 
product was obtained as a yellow solid (0.178 g, 59.3%). M.p. 
= 275-277C;  1H-NMR  
 (DMSO-d6)   / ppm: 3.04 (s, phen-CH3, 3H), 7.07 (brs, NH2, 
2H), 7.35 (brs, NH=C-NH-C=NH, 3H), 7.70 – 7.75 (m, phen-
H2, phen-H3, 2H), 8.01 (d, phen-H9, 1H, J9-10 = 8.88 Hz), 
8.16 (d, phen-H4, 1H, J3-4 = 7.86 Hz), 8.43 (s, phen-H7, 1H), 
8.68 (d, phen-H1, 1H, J1-2 = 7.86 Hz), 8.77 (d, phen-H10, 2H, 
J9-10 = 8.94 Hz), 10.24 (s, NH, 1H); 13C-NMR (DMSO-d6)  / 
ppm):  22.46(phen-CH3), 116.32 (phen-H7), 122.33 (phen-
H1), 123.28, 123.47 (phen-H10), 125.64, 125.89, 126.38, 
126.84 and 128.30 (phen-H2 and phen-H2), 127.74, 138.47, 
154.89, 158.33, 159.03, 161.34; IR (KBr)  (cm-1): 619, 766, 
851, 874, 1041, 1155, 1221, 1242, 1340, 1365, 1404, 1487, 
1508, 1519, 1560, 1637, 1651, 1917, 2345, 2630, 3024, 3082, 
3178, 3292, 3363; ES-MS m/z for C16H16N6 (Mr=292.35 
gmol-1)  293.147 [M+H]+; HRMS (MALDI / TOF) for 
C16H16N6 [M+H]+ Mr calcd = 293.1509; Mr found= 293.1520. 
Synthesis of  1,-(6-methylphenanthridine-3,8-diyl)dibiguanide 
∙ 3HCl (6) 
To a solution of 3,8-diamino-6-methylphenanthridine (4; 0.15 
g, 0.67 mmol) and 3M hydrochloric acid (480l, 0.049 g, 
1.345 mmol) was added dicyandiamide (0.113 g, 1.345 
mmol). The resulting suspension was stirred at 90-100C for 
3-4 hours. The reaction mixture was then dissolved in 
methanol and filtered off to give a light brown solid (0.147 g, 
47%). The product was further purified by dissolving in water 
(10 ml) and treating with DOWEX(R) 1 X 2, Cl(-)-form ion 
exchange resin at room temperature. It was then filtered over 
an activated Varian’s ‘Bondelut’ Mega Be-C18 column 
(activated with 10 ml methanol, 10 ml water), the remainder 
was eluted from the column using 2% methanol / water and 
evaporated to 0.12 g of a brown solid (38.5%). M.p. = 
>320C; 1H-NMR (DMSO-d6)   / ppm: 2.81 (s, phen-CH3, 
3H), 7.12 (brs, NH2, 2H), 7.19 (brs, NH2, 2H), 7.40 (brs, 
NH=C-NH-C=NH, 6H), 7.53 (d, phen-H2, 1H, J1-2 = 7.92 Hz), 
7.80 (d, phen-H9, 1H, J9-10 = 7.62 Hz), 8.03 and 8.25 (s, phen-
H4, phen-H7, 2H), 8.49 (d, phen-H1, 1H, J1-2 = 8.88 Hz), 8.59 
(d, phen-H10, 1H, J9-10 = 9.18 Hz), 10.22 and 10.30 (s, NH, 
2H); 13C-NMR (DMSO-d6)   / ppm:  22.91 (phen-CH3), 
116.10 and 118.32 (phen-H7, phen-H4), 118.85, 120,06 
(phen-H2), 122.56 (phen-H1), 122.97 (phen-H10), 124.78 
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(phen-H9), 125.10, 127.67, 137.68, 138.71, 154.93, 155.08, 
158.48, 161.29, 161.40, 162.73;  IR (KBr)  (cm-1): 602, 669, 
825, 1005, 1116, 1138, 1396, 1489, 1541, 1564, 1624, 1653, 
1743, 2343, 2360, 2924, 3215, 3404; ES-MS m/z for 
C18H21N11 (Mr=391.44 gmol-1)  392.212 [M+H]+, 196.614 
[M+2H]2+; HRMS (MALDI / TOF) for C18H21N11 [M+H]+ Mr 
calcd = 392.2054; Mr found= 392.2051. 
Materials and methods 
1H NMR and 13C NMR spectra were recorded on a Brucker 
AV300 or Brucker AV600 (at 300 and 600 MHz) at 25oC. 
Chemical shifts (d) were given in parts per million (ppm) 
relative to tetramethylsilane as an internal standard and 
coupling constants (J) in hertz. The splitting patterns in the 1H 
NMR spectra are denoted as follows: s (singlet), brs (broad 
singlet), d (doublet), t (triplet), m (multiplet). Melting points 
were determined on a Kofler melting points apparatus and are 
uncorrected. Infrared spectra were recorded on a BOMEM 
MB 102 spectrophotometer and spectral bands are expressed 
in ‘wave numbers’ with the unit cm-1. Mass spectra were 
obtained using BRUKER micrOTOF spectrometer and Waters 
Micromass ZQ. The pH measurement was carried out using 
Mettler TOLEDO MP220 pH meter calibrated with 
commercially available buffered aqueous solutions of pH 
standards 4.00 and 7.00. The UV/vis spectra were recorded on 
a Varian Cary 100 Bio spectrophotometer, CD spectra on 
JASCO J815 spectrophotometer and fluorescence spectra on a 
Varian Cary Eclipse spectrophotometer at 25oC using 
appropriate 1cm path quartz cuvettes. For study of 
interactions with DNA and RNA, aqueous solutions of 
compounds buffered to pH 5.0 (citric acid/NaOH buffer, 
I=0.03 mol dm-3) and pH 7.0 (buffer sodium cacodylate, 
I=0.05 mol dm-3) were used.  
Relative fluorescence quantum yields (Q) were determined by 
the standard procedure59. All samples were purged with argon 
to displace oxygen, and emission spectra were recorded from 
350–600 nm and corrected for the effects of time- and 
wavelength-dependent light-source fluctuations by use of a 
rhodamine 101 standard, a diffuser and the software provided 
with the instrument. As the standard we used l-N-
acetyltryptophanamide (NATA, Fluka, Buchs, Switzerland) 
with published fluorescence quantum yield Q=0.14.60 The 
NATA concentration in fluorescence measurements had an 
optical absorbance below 0.05 at the excitation wavelength 
while 5 and 6 had optical absorbencies between 0.06 and 0.15 
at the excitation wavelength.  
Polynucleotides were purchased as noted: poly rA–poly rU , 
poly dG–poly dC, poly dA–poly dT, poly(dAdT)2 (Sigma), 
calf thymus (ct)-DNA (Aldrich). Polynucleotides were 
dissolved in Na-cacodylate buffer, I=0.05 mol dm-3, pH 7.0. 
The calf thymus ctDNA was additionally sonicated and 
filtered through a 0.45 mm filter.61 Polynucleotide 
concentration was determined spectroscopically as the 
concentration of phosphates. Spectrophotometric titrations 
were performed at pH 5.0 (I=0.03 mol dm-3, citric acid/NaOH 
buffer) and pH 7.0 (I=0.05 mol dm-3, buffer sodium 
cacodylate) by adding portions of polynucleotide solution into 
the solution of the studied compound for UV/vis and 
fluorimetric experiments and for CD experiments were done 
by adding portions of compound stock solution into the 
solution of polynucleotide. In fluorimetric experiments 
excitation wavelength of exc300 nm was used to avoid the 
inner filter effect caused due to increasing absorbance of the 
polynucleotide. Emission was collected in the range em=380–
600 nm. Processing titration data by means of Scatchard 
equation32 gave values of ratio n=0.1±0.05. Values for Ks 
given in Table 3 all have satisfactory correlation coefficients 
(>0.99). Thermal melting curves for DNA, RNA and their 
complexes with studied compounds were determined as 
previously described29,38 by following the absorption change 
at 260 nm as a function of temperature. Absorbance of the 
ligands was subtracted from every curve and the absorbance 
scale was normalized. Tm values are the midpoints of the 
transition curves determined from the maximum of the first 
derivative and checked graphically by the tangent method.29 
The Tm values were calculated subtracting Tm of the free 
nucleic acid from Tm of the complex. Every ΔTm value here 
reported was the average of at least two measurements. The 
error in Tm is ±0.5oC.  
Viscometry measurements were conducted with an Ubbelohde 
viscometer system AVS 370 (Schott). The temperature was 
maintained at 25 +/- 0.1 °C. Aliquots of drug stock solutions 
were added to 2.5 ml of 5  10-4 mol dm-3 polynucleotide 
solution in buffer sodium cacodylate, I = 0.05 mol dm-3, pH 
7.0, with a compound to polynucleotide phosphate ratio r less 
than 0.2. Dilution never exceeded 4% and was corrected for in 
the calculations. The flow times were measured at least five 
times optically with a deviation of +/- 0.2 s. The viscosity 
index  was obtained from the flow times at varying r 
according to the following equation:62  
 
L/L0 = [ ( tr – t0 ) / ( tpolynucleotide – t0 ) ] 1/3  =  1 + *r 
 
Where t0, tpolynucleotide and tr denote the flow times of buffer, 
free polynucleotide and polynucleotide complex at ratio 
r[compound] / [polynucleotide] , respectively; L/L0 is the relative 
DNA/RNA lengthening. The L/L0  to r[compound] / [polynucleotide] -
plot was fitted to a straight line that gave slope . The error in 
 is < 0.1. 
SERS spectroscopy 
Chemicals: Silver nitrate (Kemika) and trisodium citrate 
(Kemika) were of analytical reagent grade and used as 
supplied for the silver colloid preparation. Water was purified 
by passage through Milli-Q (Millipore) deionizing and 
filtration columns. Cacodylate buffer contained 0.05 mol dm-3 
sodium cacodylate adjusted to pH 7.0 by 0.1 mol dm-3 HCl. 
Colloid preparation: Before preparation of colloid all 
glassware was thoroughly cleaned with a detergent solution, 
followed by treatment in 5 % nitric acid, and finally rinsed 
with water of Milli-Q purity. Silver colloid was prepared 
according to a modified Lee and Meisel reduction method 
with citrate.63,64 Silver nitrate (18 mg) was suspended in water 
(100 mL) and heated rapidly to boiling under stirring. A 1 % 
(w/v) trisodium citrate aqueous solution (2 mL) was added to 
the boiling solution and kept boiling gently for 90 min with 
continuous stirring. The resulting colloidal solution was 
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greenish yellow with the maximum at 424 nm in the UV/Vis 
absorption spectrum. pH value of the prepared colloid was 
6.9. 
Samples preparation: SERS spectra of the biguanide species 
were measured in the silver citrate colloid. Samples with 
ctDNA were prepared by mixing the silver citrate colloid (425 
L), the 5 or 6 stock solution (50 L, c = 510–4 mol dm-3) 
and ctDNA (25 L, c = 210–2 mol dm-3). The resulting 
[5,6]/[phosphate] ratio was 1/20. To study the effect of the 
cacodylate buffer on the biguanide SERS spectra, samples 
were prepared in the same way but adding the buffer solution 
instead of the nucleic acid. In all working samples the final 
concentration of the biguanide species was 510–5 mol dm-3. 
Instrumentation: FT-Raman and SERS spectra were measured 
on a Bruker Equinox 55 interferometer equipped with a FRA 
106/S Raman module using Nd-YAG laser excitation at 1064 
nm and a laser power of 500 mW. Raman spectra were taken 
in the 3500–100 cm–1 range. To obtain good spectral 
definition, 128 scans at a spectral resolution of 4 cm–1 were 
averaged for each spectrum. UV/Vis absorption measurement 
of the silver citrate colloid was carried out with an Analytik 
Jena spectrometer (model SPECORD 200). Conventional 
quartz cells (10 mm × 10 mm) were used throughout. For pH 
measurements, a Mettler Toledo pH meter (model MP 220) 
with a Mettler Toledo InLab®413 combined glass-calomel 
electrode was used. The pH meter was calibrated with 
standard aqueous buffer solutions of pH 7.00 and 4.01. 
 Cell cultures and MTT assay 
Cell culturing: Human tumour cell lines, stomach epithelial 
gastric adenocarcinoma (AGS), pancreatic carcinoma 
(MiaPaCa2), colon adenocarcinoma (CaCo-2),  larynx 
carcinoma (HEp-2), cervix adenocarcinoma (HeLa), 
bronhoalveolar carcinoma (NCI-H358), normal human 
foreskin cell line (BJ) fibroblast morphology between 27-29 
passages and Madine-Darby canine kidney (MDCK) cells 
between 24-26 passages, were cultured in tissue culture flasks 
(25.75 cm2) and grown as monolayer’s. Cells were cultured in 
Dulbecco’s modified Eagle medium – DMEM (Gibco, EU) 
supplemented with 10% heat-inactivated foetal bovine serum 
(FBS, Gibco, EU), 2mM glutamine, and 100U/0.1mg 
penicillin/streptomycin. AGS and NCI-H358 cell lines were 
cultivated in RPMI 1640 (Gibco, EU) medium supplemented 
with 10% heat-inactivated foetal bovine serum (FBS, Gibco, 
EU), 2 mmol dm-3  glutamine, 1mmol dm-3  sodium pyruvate, 
10 mmol dm-3  HEPES and 100U/0,1 mg 
penicillin/streptomycin. To detach from flask surface, cells 
were trypsinized using 0.25% trypsin/EDTA solution. Cells 
were culture in humidified atmosphere under the condition of 
37°C/5% of CO2 gas in the CO2 incubator (Shell Lab, Sheldon 
Manufacturing, USA). 
 Cytotoxicity evaluation by MTT assay:65 Tested 
compounds (5, 6) were prepared as stock solutions (5  10-3 mol 
dm-3) in high pure water with addition of 5.2%  of 0.1 mol dm-3 
HCl (5) and 4.9% of 0.1 mol dm-3 HCl (6). Influence of added 
HCl was evaluated through the percentage range like it was in the 
range of tested substances. Addition of HCl in solutions had no 
effect on their ability to suppress cell growth. Working solutions 
(10-3 – 10-6 mol dm-3) were prepared prior to testing. Cytotoxic 
effects were determined by MTT assay. Cells were seeded in 96 
micro well flat bottom plates (Greiner, Frickenhausen, Austria) at 
concentration 2  104 cells/mL and left overnight in the CO2 
incubator allowing them to attach to the plate surface. 72 h after 
compound addition growth medium was discarded and 5mg/mL 
of MTT was added. After 4h incubation at 37°C water insoluble 
MTT-formazan crystals were dissolved in DMSO. Plates were 
shaken at high speed to ensure total dissolution of crystals which 
is pre request for absorbance measuring. Absorbance was 
measured at 570 nm on Elisa micro plate reader (Stat fax 2100, 
Pharmacia Biotech, Uppsala, Sweden). Control, none treated, 
cells were grown under the same conditions. All experiments 
were performed at least three times in triplicates. The IC50,  a 
compound concentration which reduced cellular viability by 50% 
compared to the viability of control cells after 72 h of treatment, 
were determined by constructing a dose-response curve and used 
as a parameter to compare cytotoxicity among tested compounds. 
STATISTIC 7 software and Kolmogorov – Smirnov two sample 
test were used to statistically evaluate data obtained from MTT 
test.  
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